Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BP
BP
|
+$16.3M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$8.25M |
| 3 |
Citigroup
C
|
+$7.9M |
| 4 |
New York Times
NYT
|
+$7.84M |
| 5 |
Pfizer
PFE
|
+$6.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$75.8M |
| 2 |
Patterson-UTI
PTEN
|
+$2.49M |
| 3 |
Astec Industries
ASTE
|
+$316K |
| 4 |
KeyCorp
KEY
|
+$45.9K |
| 5 |
Chevron
CVX
|
+$34.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.13% |
| 2 | Healthcare | 24.17% |
| 3 | Energy | 12.29% |
| 4 | Communication Services | 12.14% |
| 5 | Technology | 4.68% |
Similar funds
Kahn Brothers's Q1 2014 Portfolio in Review
As of Q1 2014, Kahn Brothers held 42 positions worth $701M, up 21% from $581M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Trading was light in Q1 2014: portfolio turnover was 0%. Kahn Brothers opened no new positions and made no exits, leaving the 42-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 34% a quarter earlier, followed by Healthcare and Energy.
- Kahn Brothers added most to BP in Q1 2014, an estimated $16.3M increase.
- Kahn Brothers's biggest Q1 2014 reduction was Merck, cutting an estimated $75.8M.
- Kahn Brothers's ten largest holdings make up 76% of its $701M portfolio in Q1 2014.
- Kahn Brothers opened 0 new positions and closed 0 in Q1 2014.
- Kahn Brothers's portfolio value rose 21% quarter-over-quarter to $701M.
Based on Kahn Brothers Group's 13F filing for Q1 2014, filed 7 May 2014.